Recent News

• 08.25.2025 - MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases
• 08.25.2025 - MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases
• 08.14.2025 - scPharmaceuticals Receives Notice of Allowances of Multiple US Patent Applications Covering SCP-111
• 08.14.2025 - scPharmaceuticals Receives Notice of Allowances of Multiple US Patent Applications Covering SCP-111
• 08.07.2025 - Second Quarter 2025 Financial Results and Conference Call
• 08.07.2025 - scPharmaceuticals Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update
• 08.07.2025 - scPharmaceuticals Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update
• 07.31.2025 - scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025
• 07.31.2025 - scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025

Recent Filings

• 08.25.2025 - SC TO-C Written communication relating to an issuer or third party
• 08.25.2025 - SC14D9C Written communication relating to third party tender offer
• 08.25.2025 - 8-K Current report
• 08.25.2025 - SC14D9C Written communication relating to third party tender offer
• 08.25.2025 - 8-K Current report
• 08.25.2025 - EX-99.1 EX-99.1
• 08.25.2025 - SC TO-C Written communication relating to an issuer or third party
• 08.07.2025 - 8-K Current report
• 08.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.07.2025 - EX-99.1 EX-99.1